Advancing a clinically relevant perspective of the clonal nature of cancer
about
Emerging role of N-myc downstream-regulated gene 2 (NDRG2) in cancerMolecular Technologies in the Clinical Diagnostic LaboratoryInterplay between genomic alterations and androgen receptor signaling during prostate cancer development and progressionSingle Cell Isolation and AnalysisIdentification of recurrent NAB2-STAT6 gene fusions in solitary fibrous tumor by integrative sequencing.PET/CT in Oncology: Current Status and Perspectives.Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers.Clonal evolution of a case of treatment refractory maxillary sinus carcinomaHeterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomicsDeep clonal profiling of formalin fixed paraffin embedded clinical samplesMetastatic progression of breast cancer: insights from 50 years of autopsies.Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.Chromosome-breakage genomic instability and chromothripsis in breast cancerPulmonary metastases in pancreatic cancer, is there a survival influence?Role of intratumoural heterogeneity in cancer drug resistance: molecular and clinical perspectivesGenomic amplification of 9p24.1 targeting JAK2, PD-L1, and PD-L2 is enriched in high-risk triple negative breast cancer.Clonal evolution and therapeutic resistance in solid tumors.Ultradense array CGH and discovery of micro-copy number alterations and gene fusions in the cancer genome.Advancing precision medicine for prostate cancer through genomics.Molecular characterization of patient-derived human pancreatic tumor xenograft models for preclinical and translational development of cancer therapeuticsGlioblastomas are composed of genetically divergent clones with distinct tumourigenic potential and variable stem cell-associated phenotypes.Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches.STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma.Elevation of β-galactoside α2,6-sialyltransferase 1 in a fructoseresponsive manner promotes pancreatic cancer metastasis.Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines.Using a systems biology approach to understand and study the mechanisms of metastasisAdaptation or selection--mechanisms of castration-resistant prostate cancer.Signal transduction in cancerRecent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer.Evidence of drug-response heterogeneity rapidly generated from a single cancer cell.Recurring DNA copy number gain at chromosome 9p13 plays a role in the activation of multiple candidate oncogenes in progressing oral premalignant lesions.Mesenchymal-like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial-like counterparts.Focal overexpression of CEACAM6 contributes to enhanced tumourigenesis in head and neck cancer via suppression of apoptosis.Interpreting gene-expression profiles in transplantation: a critical appraisalClonality inference in multiple tumor samples using phylogeny.The genomic landscape of prostate cancer.Biomarker-based targeting of the androgen-androgen receptor axis in advanced prostate cancerPancreatic cancer: Classifying pancreatic cancer using gene expression profilingClinical study of genomic drivers in pancreatic ductal adenocarcinoma.
P2860
Q26778509-EAC3B7F3-C276-4DA3-9A6D-9261ED8AA00BQ26996463-433AD45C-2B88-4918-A0E3-60FE3995C120Q27022288-849035D8-6383-4172-BBD7-9FD32779B0E7Q28078083-B87E247D-5C43-400A-A427-9C51D7A82401Q33405269-F70A55A8-51C4-404A-BD4A-C07CE3B6B85AQ33665109-9A6144C3-5CC0-4571-8BFB-1AC5006B4894Q33685000-0D72BE5C-2CC0-4617-9760-D431C932DCDFQ34429603-53BE84B8-F9F3-48CA-BDB1-43963780A563Q34468269-EF775968-5E7C-42C2-AE5C-40DB63A8228CQ34505542-EB78D09F-5897-4B01-A66C-E62F90E8F5C7Q34891023-D24F0C0B-2974-489D-AE95-4D21F818BFEAQ35088118-C592A8D4-CD1F-458C-8D84-890B5F458D31Q35204806-8C67414E-C39C-4498-B8DE-7EDB1C6D823FQ35419454-7A697A1C-5641-412E-8F43-FB321D6417ECQ36386428-A608755D-2267-4260-9575-D520B757964EQ36413493-A9232073-F635-4E1A-8743-9AFE6885CDAAQ36566531-BB87A9B4-81BA-4C04-93B7-FD2A65B783D3Q36954610-44D6271F-17BE-49CD-A662-2E0A17E3F3B3Q37255151-7D25F34F-CBD2-4FE6-A62D-B8D0A2AA0A9AQ37285542-61F357B1-456C-45E4-848B-98C725ADE0FBQ37491359-E9F1AAE3-7262-453E-8FD8-BA96A6AA7F69Q37537958-B824E5B8-8D9E-4001-97C9-773D259FAE21Q37676840-B7635B8B-C4A4-4FF5-9261-0505B6C726E4Q37702592-36F478D9-D91C-4DB7-9D15-E104E8732B2EQ37703226-B510BF94-DCD7-44E0-ACC0-77D42F0DE43AQ37721685-60AA92FB-EA81-48C7-BF14-26FD566037D8Q38068116-713E9C55-83EF-4A3F-A7C2-6D843033C454Q38400912-F1538F70-CB41-4E50-81C0-6299BB813A7CQ38449763-3A297454-735E-46E2-A735-83A0EBF7C7FDQ38608075-A1154F8B-886F-4548-A9F5-7173F4D1C22DQ38705076-FA2E26AE-8599-4EAE-9827-831CD4110FD9Q38971913-7793CF05-9432-41E6-8DC3-A3C90FED06CAQ38994193-3ACCF160-0136-40C2-84FB-2193C7533DBFQ39269702-D6BB7703-0D61-4807-A22F-ACA942ACC4FAQ40740504-E29E7C2F-0432-4958-BFEE-D9105539C355Q41610580-C001C519-AE48-4EC1-9D84-3E7AAE3B0F60Q42174920-49B7F8EF-9518-4A13-B305-B67F8EDAF614Q42322498-954B058B-670A-4D07-BB72-D28164FE2824Q42397589-7BC2E4E2-0603-4C32-B0CF-065605CC9E63Q45063614-6B5C129B-2E9B-4C8B-9426-747AAB3AE180
P2860
Advancing a clinically relevant perspective of the clonal nature of cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Advancing a clinically relevant perspective of the clonal nature of cancer
@ast
Advancing a clinically relevant perspective of the clonal nature of cancer
@en
type
label
Advancing a clinically relevant perspective of the clonal nature of cancer
@ast
Advancing a clinically relevant perspective of the clonal nature of cancer
@en
prefLabel
Advancing a clinically relevant perspective of the clonal nature of cancer
@ast
Advancing a clinically relevant perspective of the clonal nature of cancer
@en
P2093
P2860
P356
P1476
Advancing a clinically relevant perspective of the clonal nature of cancer
@en
P2093
Alex Robeson
Christian Ruiz
Daniel Von Hoff
Donna Prunkard
Elizabeth Lenkiewicz
Jeffrey Kiefer
Jeffrey M Trent
John D Carpten
Lisa Evers
Lukas Bubendorf
P2860
P304
12054-12059
P356
10.1073/PNAS.1104009108
P407
P577
2011-07-05T00:00:00Z